Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regions Financial B Pref | RF-B | May 17, 2024 | 25.00 | -0.48 |
Regions Financial C Pref | RF-C | May 17, 2024 | 22.85 | -0.04 |
Regions Financial E Pref | RF-E | May 17, 2024 | 17.93 | -0.11 |
Regis | RGS | May 17, 2024 | 6.25 | 0.00 |
Regulus Therapeutics | RGLS | May 17, 2024 | 2.00 | 0.00 |
Reinsurance Group of America | RGA | May 17, 2024 | 212.37 | +1.02 |
REIT Index ETF Vanguard | VNQ | May 17, 2024 | 84.89 | -0.01 |
Rekor Systems | REKR | May 17, 2024 | 1.32 | -4.35 |
Relay Therapeutics | RLAY | May 17, 2024 | 6.64 | +2.00 |
Reliance | RS | May 17, 2024 | 298.37 | +0.10 |
Reliance Global | RELI | May 17, 2024 | 0.31 | +7.86 |
Relmada Therapeutics | RLMD | May 17, 2024 | 3.34 | -4.30 |
RELX ADR | RELX | May 17, 2024 | 44.07 | +0.34 |
Renaissance Ipo ETF | IPO | May 17, 2024 | 39.66 | +0.97 |
RenaissanceRe | RNR | May 17, 2024 | 229.43 | +1.14 |
RenaissanceRe G Pref | RNR-G | May 17, 2024 | 17.92 | -0.89 |
RenaissanceRe Holding F Pref | RNR-F | May 17, 2024 | 23.34 | -0.19 |
Renalytix ADR | RNLX | May 17, 2024 | 0.51 | -12.87 |
Renasant | RNST | May 17, 2024 | 30.95 | -0.48 |
Reneo Pharmaceuticals | RPHM | May 17, 2024 | 1.75 | +5.42 |
ReNew Energy Global A Shares | RNW | May 17, 2024 | 5.93 | -8.06 |
Renn Fund | RCG | May 17, 2024 | 1.61 | +0.62 |
Renovaro Biosciences | RENB | May 17, 2024 | 0.97 | +5.75 |
RenovoRx | RNXT | May 17, 2024 | 1.37 | -6.16 |
Rent The Runway A | RENT | May 17, 2024 | 33.53 | +13.89 |
Rentokil Initial ADR | RTO | May 17, 2024 | 27.30 | -0.58 |
Repare Therapeutics | RPTX | May 17, 2024 | 3.55 | +0.57 |
Repay A | RPAY | May 17, 2024 | 10.18 | +0.89 |
Repligen | RGEN | May 17, 2024 | 171.94 | +0.53 |
Replimune Group | REPL | May 17, 2024 | 6.44 | -4.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.